Alert Done Done Edit In progress Play Run workshop Download Down Close All modules Educator In progress Learner How to Delete Information Credits Undo Time Left Right Right Down Locked Hide Home Menu Twitter LinkedIn icons.facebook Plus

The latest publications, provided with practical advice

Going beyond a simple summary, these 30-minute videos provide specific guidance on how the latest data can be applied in your clinical setting, and the impact it can have on your patients.

Each session provides a succinct synopsis of a recent publication and a discussion of its impact on practice. Next, an expert of your choice will guide you through what this new data means in the context of your local clinical setting.

Available Modules

Accreditation Expired

2020 updates in treating NTRK fusion cancer

Professor Dr. Marc Peeters
Dr Drilon Dr Alexander Drilon

Abstracts from 2020

Accreditation Expired

Treating TRK fusion cancer: Selecting between available agents

Professor Dr. Marc Peeters
Dr. David Hong

A summary of available RCT data for TRKis

Accreditation Expired

2019 updates in treating NTRK fusion cancer

Professor Dr. Marc Peeters
Professor Jesus Garcia-Foncillas

Highlights from ESMO 2019

Accreditation Expired

The challenge of detecting NTRK fusions across tumour types

Professor Dr. Marc Peeters
Professor Caterina Marchiò

Critiquing testing approaches

Accreditation Expired

REGOSARC – activity of regorafenib in advanced non-adipocytic STS

Professor Florence Duffaud
Professor Jean-Yves Blay

Initial data of regorafenib in soft tissue sarcoma

Accreditation Expired

Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort

Professor Jean-Yves Blay
Professor Florence Duffaud

Implications of the REGOBONE trial

Accreditation Expired

Appraising an NTRK testing algorithm: When, what, how

Professor Jean-Yves Blay
Professor Frédérique Penault-Llorca

An introduction to NTRK gene fusions

Accreditation Expired

Optimising regorafenib dosing in mCRC

Dr. Axel Grothey
Dr. Tanios Bekaii-Saab

Evaluating the REDOS trial and its relevance to clinical practice

Accreditation Expired

Optimising adjuvant chemotherapy in Stage III CRC

Dr. Axel Grothey
Dr. Tim Iveson

What does the IDEA study teach us about the use of oxaliplatin in colorectal cancer?

Accreditation Expired

Future directions in glioblastoma: the potential role of TKIs

Dr. Roger Stupp
Professor Giuseppe Lombardi

Evaluating the REGOMA trial and its relevance to clinical practice

Accreditation Expired

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma

Professor Josep Llovet
Dr. Richard Finn

Exploring the RESORCE trial and second-line systemic therapy in advanced HCC